08.30 EXCEMED institutional opening and introduction
D. Bates (UK) - G. Comi (Italy) - A. Siva (Turkey)
Local welcome
J. Inshasi (UAE)
Chairs: G.Comi (Italy) and I.Sharooqi (Kuwait)
Real-time survey
09.00 L1: Epidemiology
S. Bohlega (Saudi Arabia)
09.20 L2: Risk factors: the role of infections and environment
Speaker to be announced
09.40 L3: Genetics of multiple sclerosis: current and emerging candidates
F. Martinelli Boneschi (Italy)
10.00 Coffee break
10.20 L4: Deciphering MS pathogenesis: the role of MRI
M.A. Rocca (Italy)
10.40 L5: Neurodegeneration: mechanisms and prevention
L.Leocani (Italy)
11.00 Discussion
Revisiting real-time survey
The workshop sessions will involve attendees in an interactive discussion, giving them the chance to share opinions and understanding of different MS related topics. There will be three sessions including six different workshops, each lasting one hour. The audience will be divided into six groups, at the end of the conference each participant will have attended all the six workshops in rotation.
1. Treatment initiation and therapeutic contract
C.Pozzilli (Italy) and speaker to be announced
2. How to manage response to first line therapies
G. Edan (France) and speaker to be announced
3. Therapeutic options
G. Comi (Italy) - P. Rieckmann (Germany)
4. Role of MRI in monitoring treatment
N. De Stefano (Italy) and speaker to be announced
5. Genes and environment
F. Martinelli Boneschi, Italy and speaker to be announced
6. Patient engagement in the decision making process
D. Langdon (UK) - A. Solari (Italy)
13.15 Lunch
Chairs: D.Bates(UK) and A.Siva (Turkey)
Real-time survey
14.15 L6: Prognosis from natural history
R. Bergamaschi (Italy)
14.35 L7: How to define non responders
R. Fox (USA)
14.55 L8: Predictivity of response to treatment
M.Tintoré (Spain)
15.15 L9: How to keep patients on treatment
C.Pozzilli (Italy)
15.35 Discussion
Revisiting real-time survey
15.50 Coffee break
1. Treatment initiation and therapeutic contract
C.Pozzilli (Italy) and speaker to be announced
2. How to manage response to first line therapies
G. Edan (France) and speaker to be announced
3. Therapeutic options
G. Comi (Italy) - P. Rieckmann (Germany)
4. Role of MRI in monitoring treatment
N. De Stefano (Italy) and M.A.Rocca (Italy)
5. Genes and environment
F. Martinelli Boneschi, Italy and Speaker to be announced
6. Patient engagement in the decision making process
D. Langdon (UK) - A. Solari (Italy)
18.30 End of the first day
1. Treatment initiation and therapeutic contract
C.Pozzilli (Italy) and speaker to be announced
2. How to manage response to first line therapies
G. Edan (France) and speaker to be announced
3. Therapeutic options
G. Comi (Italy) and P. Rieckmann (Germany)
4. Role of MRI in monitoring treatment
N. De Stefano (Italy) and speaker to be announced
5. Genes and environment
F. Martinelli Boneschi (Italy) and Speaker to be announced
6. Patient engagement in the decision making process
D. Langdon (UK) and A. Solari (Italy)
10.30 Coffee break
Real-time survey
10.50 Introduction
B. Yammout (Lebanon)
11.15 Patient’s perception and patients’ reported outcomes – round table
Chairs: D. Bates (UK) and B. Yammout (Lebanon), I. Slassi (Morocco)
D. Langdon (UK),M. A. Sahraian (Iran) and I. A. Slassi (Morocco)
Chairs: D.Bates(UK) and J.Inshasi (UAE)
Experts will debate different topics related to the MS environment. Each debate will be conducted by two speakers presenting two different points of view; at the end attendees will vote for the most convincing position. Attendees will have the chance to discuss the debate outcomes with the experts.
11.50 D1: Treatment initiation
Start immediately vs Wait and see
G. Comi (Italy) A. Siva (Turkey)
Audience poll
12.35 D2: Assessing treatment failure
MRI matters vs Clinical response only
N. De Stefano (Italy) V.Martinelli (Italy)
Audience poll
13.20 Discussion
Revisiting real-time survey
13.30 Lunch
14.30 Q&A - Let's talk
Messages: let's recap
Scientific committee
16.30 End of the conference